H. Kondoh

[Reproductive and developmental toxicity studies of paclitaxel. (III)--Intravenous administration to rats during the perinatal and lactation periods].

T. Kadota, H. Kohmura, S. Koizumi, 1994, The Journal of toxicological sciences.

Phase I and pharmacokinetic study of KRN5500, a spicamycin derivative, for patients with advanced solid tumors.

H. Ono, Y. Tanigawara, Y. Matsumura, 2003, Japanese journal of clinical oncology.

[Reproductive and developmental toxicity studies of paclitaxel. (I)--Intravenous administration to rats prior to and in the early stages of pregnancy].

S. Koizumi, S. Kai, H. Kohmura, 1994, The Journal of toxicological sciences.

[Toxicity studies of paclitaxel. (I)--Single dose intravenous toxicity in rats].

T. Kadota, S. Koizumi, E. Hiraiwa, 1994, The Journal of toxicological sciences.

[Toxicity studies of paclitaxel. (III)--Six-month intermittent intravenous toxicity in rats].

T. Kadota, S. Koizumi, E. Hiraiwa, 1994, The Journal of toxicological sciences.

[Irritability study of paclitaxel in rabbit ear vein].

T. Kadota, S. Koizumi, K. Ishikawa, 1994, The Journal of toxicological sciences.

[Reproductive and developmental toxicity studies of paclitaxel. (II)--Intravenous administration to rats during the fetal organogenesis].

S. Koizumi, S. Kai, H. Kohmura, 1994, The Journal of toxicological sciences.

[Cefepime (diHCl/L-arginine blend): intravenous continuous infusion and/or single dose subcutaneous toxicity study in rats and dogs].

T. Kadota, K. Ishikawa, S. Kawano, 1992, The Japanese journal of antibiotics.